SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-017052
Filing Date
2022-06-17
Accepted
2022-06-17 09:00:12
Documents
17
Period of Report
2022-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41739
2 ex10-1.htm EX-10.1 271202
3 ex10-1_001.jpg GRAPHIC 115384
4 ex10-1_003.jpg GRAPHIC 4322
5 ex10-1_004.jpg GRAPHIC 4315
6 ex10-1_005.jpg GRAPHIC 4326
  Complete submission text file 0001493152-22-017052.txt   684980

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aim-20220613.xsd EX-101.SCH 2959
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aim-20220613_lab.xml EX-101.LAB 34916
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aim-20220613_pre.xml EX-101.PRE 22790
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3653
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 221022513
SIC: 2836 Biological Products, (No Diagnostic Substances)